- Trials with a EudraCT protocol (20)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
20 result(s) found for: Cochlear.
Displaying page 1 of 1.
EudraCT Number: 2017-002377-19 | Sponsor Protocol Number: 1456/2017 | Start Date*: 2017-09-15 |
Sponsor Name:Abteilung für Hals-, Nasen- und Ohrenkrankheiten MUW, AKH Wien | ||
Full Title: Triamcinolone levels in cochlear perilymph | ||
Medical condition: In this study triamcinolone acetonide levels after intratympanic application in the perilymph, and serum of patients receiving a cochlear implant will be studied. In patients undergoing a translaby... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002672-25 | Sponsor Protocol Number: STR001-201 | Start Date*: 2015-11-18 |
Sponsor Name:Strekin AG | ||
Full Title: A Phase II multicenter, placebo-controlled, proof-of-concept study evaluating the safety, and efficacy of intratympanic STR001 thermogel to preserve residual hearing in adults undergoing cochlear ... | ||
Medical condition: Prevention of Hearing Loss after Cochlear Implant Surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) ES (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-003929-34 | Sponsor Protocol Number: AUT042063 | Start Date*: 2016-03-10 | |||||||||||
Sponsor Name:Autifony Therapeutics Limited | |||||||||||||
Full Title: A Pilot Double-blind, Placebo-controlled Crossover Study to Explore the Possible Benefit of AUT00063, an Oral Modulator of Voltage-gated Potassium Channels, in Adult Post-lingual Unilateral Cochlea... | |||||||||||||
Medical condition: Impaired speech understanding in users of cochlear implants | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002317-19 | Sponsor Protocol Number: KKSH155 | Start Date*: 2020-04-17 | |||||||||||
Sponsor Name:Martin-Luther-Universität Halle-Wittenberg | |||||||||||||
Full Title: Prophylactic nimodipine treatment for hearing preservation after vestibular schwannoma surgery: a randomized multi-center phase III trial | |||||||||||||
Medical condition: Vestibular schwannomas with indication for surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005002-22 | Sponsor Protocol Number: PROHEARING | Start Date*: 2013-12-06 | |||||||||||
Sponsor Name:Hannover Medical School | |||||||||||||
Full Title: ACEMg mediated hearing preservation in cochlear implant patients receiving different electrode lengths | |||||||||||||
Medical condition: Cochlear implant patients in whom a cochlear implant preserving residual hearing is medically indicated | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000463-29 | Sponsor Protocol Number: BAY 38-9456 / 12049 | Start Date*: 2006-08-07 |
Sponsor Name:Bayer Healthcare AG | ||
Full Title: Evaluation of vardenafil for the treatment of subjective tinnitus: A controlled pilot study | ||
Medical condition: chronic tinnitus | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001863-60 | Sponsor Protocol Number: 04/2019 | Start Date*: 2019-08-30 |
Sponsor Name:Abteilung für Hals-, Nasen- und Ohrenkrankheiten MUW, AKH Wien | ||
Full Title: Cerebrospinal fluid levels of triamcinolone acetonide | ||
Medical condition: In this study triamcinolone acetonide levels after intratympanic application in the cerebrospinal fluid will be studied. Patients undergoing surgery with dura access will be asked to participate. P... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005215-46 | Sponsor Protocol Number: VS_Nimodipine | Start Date*: 2021-02-19 |
Sponsor Name:Department of Neurosurgery, Medical University of Vienna | ||
Full Title: Intraoperative application of nimodipine to the facial and cochlear nerves during vestibular schwannoma resection to avoid spasm-related postoperative facial paralysis and deafness - a prospective ... | ||
Medical condition: Patients with vestibularis schwanomma undergoing microsurgical resection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-018046-38 | Sponsor Protocol Number: 1-09 | Start Date*: 2010-07-08 |
Sponsor Name:Phafag AG | ||
Full Title: Double blind, placebo-controlled randomized clinical trial to evaluate the efficacy and safety of a transtympanic treatment of tinnitus with caroverine | ||
Medical condition: Caroverine infusions have been used successfully in Austria to treat cochlear-synaptic tinnitus. This treatment is very time consuming and needs a constant monitoring of the physician. This study w... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-005587-26 | Sponsor Protocol Number: AM-101-CL-12-01 | Start Date*: 2014-05-27 | |||||||||||
Sponsor Name:Auris Medical Inc. | |||||||||||||
Full Title: Efficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 2 (TACTT2) | |||||||||||||
Medical condition: Acute peripheral tinnitus following traumatic cochlear injury or otitis media | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004323-33 | Sponsor Protocol Number: AC102-201 | Start Date*: 2022-05-06 |
Sponsor Name:AudioCure Pharma GmbH | ||
Full Title: Phase II, Multi-Center, Randomized, Blinded Study Evaluating the Efficacy, Safety and Tolerability of a Single Intratympanic Dose of AC102 Compared to Oral Steroids for the Treatment of Idiopathic ... | ||
Medical condition: Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) ISSNHL is most commonly defined as sensorineural hearing loss of 30dB or greater over at least three contiguous audiometric frequencies occurri... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Trial now transitioned) CZ (Trial now transitioned) BG (Prematurely Ended) AT (Trial now transitioned) NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002602-36 | Sponsor Protocol Number: KKSH-127 | Start Date*: 2016-06-21 |
Sponsor Name:Martin-Luther-Universität Halle-Wittenberg | ||
Full Title: Efficacy and safety of high dose glucocorticosteroid treatment for idiopathic sudden sensorineural hearing loss (HODOKORT) | ||
Medical condition: Idiopathic sudden sensorineural hearing loss | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004099-20 | Sponsor Protocol Number: AM-101-CL-12-02 | Start Date*: 2013-10-30 | |||||||||||
Sponsor Name:Auris Medical AG | |||||||||||||
Full Title: Efficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 3 (TACTT3) | |||||||||||||
Medical condition: acute peripheral tinnitus following traumatic cochlear injury or otitis media | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) DE (Completed) AT (Completed) GB (Completed) PL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004697-28 | Sponsor Protocol Number: 523001.01.099 | Start Date*: 2012-06-01 | |||||||||||
Sponsor Name:Dr. W. Schwabe GmbH & Co. KG | |||||||||||||
Full Title: Randomised, double-blind trial to compare the treatment effects of Ginkgo biloba extract EGb 761® and pentoxifylline in patients with sub-chronic and chronic tinnitus focussing on psycho-social pro... | |||||||||||||
Medical condition: chronic or sub-chronic tinnitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005278-40 | Sponsor Protocol Number: ABR-55752 | Start Date*: 2016-11-29 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Molecular imaging before and during (chemo-) radiotherapy in patients with locally advanced Head and Neck, thoracic and pelvic tumors: prognostic and predictive value of 18F-fluoroazomycin arabinos... | |||||||||||||
Medical condition: Head and neck squamous cell carcinoma (HNSCC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000079-38 | Sponsor Protocol Number: DB-OTO-001 | Start Date*: 2023-05-09 | |||||||||||
Sponsor Name:Decibel Therapeutics | |||||||||||||
Full Title: A Phase 1/2, Open-Label, Multicenter Trial With a Single Ascending Dose Cohort With Unilateral Intracochlear Injection Followed by a Bilateral Injection Expansion Cohort to Evaluate the Safety, Tol... | |||||||||||||
Medical condition: Congenital auditory neuropathy secondary to biallelic mutations of the otoferlin gene (hOTOF) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001393-34 | Sponsor Protocol Number: MNILCAPS001 | Start Date*: 2014-04-14 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: Ilaris® (canakinumab) efficacy and safety in CAPS patients without confirmed mutation on exon 3 of gene CIAS1 and young (<2yrs) CAPS patients with severe neurological (CINCA) phenotype. | |||||||||||||
Medical condition: Cryopyrin-Associated Periodic Syndromes | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002548-26 | Sponsor Protocol Number: 0139 | Start Date*: 2020-12-16 | ||||||||||||||||
Sponsor Name:Royal College of Surgeons in Irlenad | ||||||||||||||||||
Full Title: Can Pentoxifylline improve long-term outcomes in preterm infants with late-onset sepsis or necrotizing enterocolitis? A pragmatic, randomised, placebo controlled trial | ||||||||||||||||||
Medical condition: Late onset sepsis & necrotising enterocolitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: IE (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005588-24 | Sponsor Protocol Number: AM-101-CL-12-03 | Start Date*: 2014-05-27 | |||||||||||
Sponsor Name:Auris Medical Inc. | |||||||||||||
Full Title: AM-101 in the Post-Acute Treatment of Peripheral Tinnitus 1 (AMPACT1) – an open-label extension to the TACTT2 study | |||||||||||||
Medical condition: Treatment of peripheral tinnitus following traumatic cochlear injury or otitis media | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001527-39 | Sponsor Protocol Number: AM-101-CL-12-04 | Start Date*: 2013-11-21 | |||||||||||
Sponsor Name:Auris Medical AG | |||||||||||||
Full Title: AM-101 in the Post-Acute Treatment of Peripheral Tinnitus 2 (AMPACT2) – an open-label extension to the TACTT3 study | |||||||||||||
Medical condition: Treatment of peripheral tinnitus following traumatic cochlear injury or otitis media | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) DE (Completed) AT (Completed) GB (Completed) PL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
